Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.
Show more...
執行長
員工
219
國家
US
ISIN
US54948U1051
上市
0 Comments
分享你的想法
FAQ
Lucira Health 今天的股價是多少?▼
LHDX 目前價格為 $0.45 USD,過去 24 小時下跌了 -19.23%。在圖表上更密切關注 Lucira Health 股票的表現。
Lucira Health 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Lucira Health 的股票以代號 LHDX 進行交易。